MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-31.86%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$241M
AUM Growth
+$241M
(-35%)
Cap. Flow
-$1.56M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Phathom Pharmaceuticals
PHAT
|
$3.23M |
Top Sells
| 1 |
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
|
$4.79M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $97.2M | 40.37% | 19,963,157 | – | – |
|
2
Aura Biosciences
AURA
$389M
| $43.1M | 17.89% | 3,039,892 | – | – |
|
3
Vaxcyte
PCVX
$4B
| $41.1M | 17.06% | 1,887,478 | – | – |
|
4
Merus
MRUS
$4.98B
| $36.2M | 15.04% | 1,600,000 | – | – |
|
|
5
Phathom Pharmaceuticals
PHAT
$864M
| $20.7M | 8.59% | 2,450,679 +382,818 | +19% | +$3.23M |
|
|
OBSV
6
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $2.53M | 1.05% | 1,570,000 | – | – |
|
|
CMPI
7
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| – | – | -1,501,716 | Closed | -$4.79M |
|